Ticker · CUSIP 53220K504

LGND

LIGAND PHARMACEUTICALS INC

Healthcare·Biotechnology

···Share

Holders (tracked)

Combined shares

225,758

Combined value

$38.91M

Last close

$223.24

Quarter

2025Q4

Tracked holders · last 8 quarters

Flat over the last 8 quarters.

Price is +29.5% vs the avg quarter-end implied price across tracked holders.

SEC event timeline

17 events

AQR Capital Management added2026-02-17
+574 shares · 2025Q4
13F
Ken Griffin (Citadel Advisors) trimmed2026-02-17
−11,246 shares · 2025Q4
13F
Wellington Management added2026-02-17
+110 shares · 2025Q4
13F
D.E. Shaw & Co. added2026-02-17
+19,037 shares · 2025Q4
13F
Steve Cohen (Point72) exited2026-02-17
−16,700 shares · 2025Q4
13F
T. Rowe Price added2026-02-17
+1,077 shares · 2025Q4
13F
Ray Dalio (Bridgewater Associates) added2026-02-13
+2,919 shares · 2025Q4
13F
Ken Fisher (Fisher Asset Mgmt) added2026-02-09
+21,932 shares · 2025Q4
13F
AQR Capital Management added2025-11-14
+1,226 shares · 2025Q3
13F
Steve Cohen (Point72) opened position2025-11-14
+16,700 shares · 2025Q3
13F
D.E. Shaw & Co. added2025-11-14
+10,363 shares · 2025Q3
13F
T. Rowe Price added2025-11-14
+947 shares · 2025Q3
13F
Wellington Management added2025-11-14
+946 shares · 2025Q3
13F
Norges Bank (Norway SWF) exited2025-11-13
−14,073 shares · 2025Q3
13F
Ray Dalio (Bridgewater Associates) opened position2025-11-13
+1,288 shares · 2025Q3
13F
Ken Fisher (Fisher Asset Mgmt) added2025-11-12
+2,860 shares · 2025Q3
13F
Norges Bank (Norway SWF) trimmed2025-11-12
−18,144 shares · 2024Q3
13F

Insider activity

No insider transactions in the last 30 days.

View full insider history for LGND →

Follow-the-investor returns

If you'd copied each holder of LGND…

Cost basis inferred from 13F share-delta history. Sorted by % return on the position they're still holding.

Investor	First in	Cost basis	Return	Position value today
T. Rowe Price	2016Q1	$44.17	+405.4%	$4.5M
Ken Fisher (Fisher Asset Mgmt)	2016Q1	$95.88	+132.8%	$29.2M
AQR Capital Management	2016Q1	$105.46	+111.7%	$1.2M
Wellington Management	2017Q2	$127.25	+75.4%	$1.9M
Ken Griffin (Citadel Advisors)	2016Q3	$173.30	+28.8%	$781K
Ken Griffin (Citadel Advisors)	2016Q3	$173.30	+28.8%	$781K
Ken Griffin (Citadel Advisors)	2016Q3	$173.30	+28.8%	$781K
D.E. Shaw & Co.	2016Q1	$184.51	+21.0%	$8.2M
D.E. Shaw & Co.	2016Q1	$184.51	+21.0%	$8.2M
Ray Dalio (Bridgewater Associates)	2025Q3	$185.42	+20.4%	$939K

Who moved on this name in 2025Q4

13F transactions reported for the latest quarter, grouped by direction.

New positions0

—

Added to6

Ken Fisher (Fisher Asset Mgmt)
+21,932
$4.1M
D.E. Shaw & Co.
+19,037
$3.6M
Ray Dalio (Bridgewater Associates)
+2,919
$552K
AQR Capital Management
+574
$109K
Wellington Management
+110
$21K
T. Rowe Price
+1,077
$204

Trimmed1

Ken Griffin (Citadel Advisors)
−11,246
$2.1M

Exited1

Steve Cohen (Point72)
−16,700
$3.0M

Institutional ownership over time

Distinct super-investors holding this ticker · combined dollar value, by quarter.

Quarter	Holders	Shares	Combined value	Δ holders
2022Q1	10	3,114,101	$14.52B	—
2022Q2	11	2,993,040	$11.12B	+1
2022Q3	11	3,243,752	$11.2M	—
2022Q4	13	3,512,338	$215.1M	+2
2023Q1	14	3,286,339	$235.3M	+1
2023Q2	11	3,224,984	$228.7M	-3
2023Q3	12	3,324,353	$195.2M	+1
2023Q4	11	3,300,519	$230.1M	-1
2024Q1	11	3,225,367	$231.4M	—
2024Q2	12	3,152,679	$264.5M	+1
2024Q3	9	186,163	$17.3M	-3
2024Q4	6	182,953	$17.9M	-3
2025Q1	8	147,388	$13.8M	+2
2025Q2	8	201,392	$20.9M	—
2025Q3	10	197,955	$31.7M	+2
2025Q4	10	225,758	$38.9M	—

Congress members trading this stock

Date	Member	Type	Amount range	Filing
2026-03-03	Gilbert Cisneros	Buy	$1K – $15K	PDF ↗
2026-01-15	Gilbert Cisneros	Buy	$1K – $15K	PDF ↗
2026-01-05	Gilbert Cisneros	Buy	$1K – $15K	PDF ↗

Who owns LGND

10 super-investors · 2025Q4

Tracked stake

225.8K

Combined value

$39M

% of shares outstanding

—

shares-out unknown

Quarter action mix

Added7Trim3

#	Manager	Shares	Value	% of book	Last action
1	Ken Fisher Fisher Asset Mgmt	130.9K	$25M	0.0%	Added+21.9K
2	D.E. Shaw & Co.	36.6K	$7M	0.0%	Added+19.0K
3	Wellington Management	8.4K	$2M	0.0%	Added+110
4	D.E. Shaw & Co.	7.6K	$1M	0.0%	Added+19.0K
5	Ken Griffin Citadel Advisors	7.4K	$1M	0.0%	Trim−11.2K
6	AQR Capital Management	5.2K	$975K	0.0%	Added+574
7	Ray Dalio Bridgewater Associates	4.2K	$795K	0.0%	Added+2.9K
8	Ken Griffin Citadel Advisors	3.5K	$662K	0.0%	Trim−11.2K
9	Ken Griffin Citadel Advisors	2.1K	$391K	0.0%	Trim−11.2K
10	T. Rowe Price	20.0K	$4K	0.0%	Added+1.1K

Recent moves

20 transactions

ADDAQR Capital Management
+574 · 2025Q4
SOLDSteve Cohen (Point72)
−16,700 · 2025Q4
ADDT. Rowe Price
+1,077 · 2025Q4
ADDWellington Management
+110 · 2025Q4
TRIMKen Griffin (Citadel Advisors)
−11,246 · 2025Q4
ADDD.E. Shaw & Co.
+19,037 · 2025Q4
ADDRay Dalio (Bridgewater Associates)
+2,919 · 2025Q4
ADDKen Fisher (Fisher Asset Mgmt)
+21,932 · 2025Q4
ADDD.E. Shaw & Co.
+10,363 · 2025Q3
ADDWellington Management
+946 · 2025Q3
ADDT. Rowe Price
+947 · 2025Q3
ADDAQR Capital Management
+1,226 · 2025Q3
NEWSteve Cohen (Point72)
+16,700 · 2025Q3
SOLDNorges Bank (Norway SWF)
−14,073 · 2025Q3
NEWRay Dalio (Bridgewater Associates)
+1,288 · 2025Q3
TRIMNorges Bank (Norway SWF)
−18,144 · 2024Q3
ADDKen Fisher (Fisher Asset Mgmt)
+2,860 · 2025Q3
ADDT. Rowe Price
+1,660 · 2025Q2
SOLDTwo Sigma Investments
−2,800 · 2025Q2
SOLDIzzy Englander (Millennium Mgmt)
−2,577 · 2025Q2

Embed this chart

Paste this iframe anywhere to embed the live LGND chart.

<iframe src="https://openstocks.me/embed/stock/LGND" width="100%" height="480" frameborder="0" loading="lazy" title="LGND chart by OpenStocks" style="border:0;border-radius:12px;background:transparent"></iframe>

Preview: https://openstocks.me/embed/stock/LGND